Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

62946

registered interest
date	19/06/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Ovarian Hyperstimulation Syndrome
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many women were admitted to hospital with ovarian hyperstimulation syndrome in each of the last five years for which figures are available; how many adverse incidents were recorded in licensed clinics in that period; and what the severity grading of each such incident was.
tabling member constituency	Heywood and Middleton
tabling member printed	Jim Dobbin
uin	201565
answer	answer is ministerial correction date of answer 24/06/2014 answer text <p>The Human Fertilisation and Embryology Authority (HFEA) has advised that the data it holds on these issues is as follows:</p><p> </p><table><tbody><tr><td><p>Year</p></td><td><p>Total number of incidents reported</p></td><td><p>Severity: Grade A</p></td><td><p>Severity: Grade B</p></td><td><p>Severity: Grade C</p></td><td><p>Not an incident/near miss</p></td></tr><tr><td><p>2009-10</p></td><td><p>497</p></td><td><p>7</p></td><td><p>308</p></td><td><p>146</p></td><td><p>36</p></td></tr><tr><td><p>2010-11</p></td><td><p>586</p></td><td><p>1</p></td><td><p>292</p></td><td><p>255</p></td><td><p>38</p></td></tr><tr><td><p>2011-12</p></td><td><p>571</p></td><td><p>3</p></td><td><p>206</p></td><td><p>308</p></td><td><p>54</p></td></tr><tr><td><p>2012-13</p></td><td><p>503</p></td><td><p>0</p></td><td><p>183</p></td><td><p>261</p></td><td><p>59</p></td></tr><tr><td><p>2013-14</p></td><td><p>506</p></td><td><p>4</p></td><td><p>203</p></td><td><p>255</p></td><td><p>44</p></td></tr></tbody></table><p> </p><p>Of these, the number of cases of Ovarian Hyperstimulation Syndrome (OHSS) reported to the Authority is as follows:</p><p> </p><table><tbody><tr><td><p>Years</p></td><td><p>Number of OHSS</p></td><td><p>Moderate</p></td><td><p>Severe</p></td></tr><tr><td><p>2009-10</p></td><td><p>121</p></td><td><p>1</p></td><td><p>120</p></td></tr><tr><td><p>2010-11</p></td><td><p>221</p></td><td><p>122</p></td><td><p>99</p></td></tr><tr><td><p>2011-12</p></td><td><p>241</p></td><td><p>196</p></td><td><p>45</p></td></tr><tr><td><p>2012-13</p></td><td><p>179</p></td><td><p>134</p></td><td><p>45</p></td></tr><tr><td><p>2013-14</p></td><td><p>192</p></td><td><p>142</p></td><td><p>50</p></td></tr></tbody></table><p> </p><p>The HFEA has also advised that licensed fertility clinics are only required to report instances of OHSS to the Authority that require a hospital admission with a severe grading, although in practice clinics often report moderate OHSS as well.</p><p> </p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 24/06/2014 16:01:09 answering member 3918 label Biography information for Jane Ellison
tabling member	446 label Biography information for Jim Dobbin

62949

registered interest
date	19/06/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	In Vitro Fertilisation
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, in how many of licensable treatment cycles at least 20 eggs were collected in the last five years for which figures are available.
tabling member constituency	Heywood and Middleton
tabling member printed	Jim Dobbin
uin	201566
answer	answer is ministerial correction date of answer 24/06/2014 answer text <p>The information requested in shown in the following table:</p><p> </p><table><tbody><tr><td><p>Years</p></td><td><p>Licensable treatment cycles where at least 20 eggs were collected</p></td></tr><tr><td><p>2008</p></td><td><p>2,910</p></td></tr><tr><td><p>2009</p></td><td><p>3,095</p></td></tr><tr><td><p>2010</p></td><td><p>3,435</p></td></tr><tr><td><p>2011</p></td><td><p>3,466</p></td></tr><tr><td><p>2012</p></td><td><p>3,464</p></td></tr><tr><td><p>2013<sup>1</sup></p></td><td><p>1,764</p></td></tr></tbody></table><p> </p><p><em>Note</em>:</p><p><sup>1</sup>The year 2013 only covers the period 1 January to 30 June 2013.</p><p> </p><p><em>Source</em>: The Human Fertilisation and Embryology Authority</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 24/06/2014 15:59:01 answering member 3918 label Biography information for Jane Ellison
tabling member	446 label Biography information for Jim Dobbin

62285

registered interest
date	17/06/2014
answering body	Department for Environment, Food and Rural Affairs
answering dept id	13
answering dept short name	Environment, Food and Rural Affairs
answering dept sort name	Environment, Food and Rural Affairs
hansard heading	Drinking Water: Contamination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Environment, Food and Rural Affairs, with reference to the Answer of 196584 6 May 2014, Official Report, column 41W, on drinking water, what plans his Department has to test for the levels of tranquillisers and antidepressants in drinking water; and if his Department will conduct a study into levels of psychotropic drugs in UK river and seawater.
tabling member constituency	Heywood and Middleton
tabling member printed	Jim Dobbin
uin	201036
answer	answer is ministerial correction date of answer 23/06/2014 answer text <p> </p><p>In 2012, the Drinking Water Inspectorate (DWI) published research looking at pharmaceuticals likely to present the worst case scenario in drinking water. Fluoxetine was included in the study, the outcome of which was that these pharmaceuticals presented no concern for public health. The research is part of an ongoing risk assessment which is revisited in the event of new information. The DWI has also responded to the earlier PQ (0019) on this matter.</p><p> </p><p> </p><p> </p><p>Monitoring river water and seawater is driven by requirements under the EU Water Framework Directive (WFD). As psychotropic drugshave not been identified as harmful chemicals under the WFD they are not routinely monitored, although they may be detected in less-specific investigations<strong>.</strong></p><p> </p><p> </p><p> </p><p>The water industry has undertaken collaborative research into chemicals in sewage effluent through the UK Water Industry Research (UKWIR) Chemicals Investigation Programme. Some medicines were included in the first Programme of 2010-13, including fluoxetine. A second Chemical Investigations Programme, beginning in 2015, will look at the psychoactive medicines fluoxetine and sertraline in sewage effluent.</p><p> </p> answering member constituency North Cornwall answering member printed Dan Rogerson question first answered 23/06/2014 10:09:48 answering member 1504 label Biography information for Dan Rogerson
tabling member	446 label Biography information for Jim Dobbin

62324

registered interest
date	17/06/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Antidepressants
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, with reference to the Answer of 19 January 2012, Official Report, columns 932-3W, how many companies hold licences for the manufacture or distribution of (a) Nitrazepam, (b) Flurazepam, (c) Loprazolam, (d) Lormetazepam, (e) Temazepam, (f) Clonazepam, (g) Medazepam, (h) Midazolam, (i) Zopiclone, (j) Zaleplon, (k) Zolpiden, (l) Eszopiclone, (m) SSRI antidepressants and (n) trycyclic antidepressants; and how many of those licences were issued in the last three years.
tabling member constituency	Heywood and Middleton
tabling member printed	Jim Dobbin
uin	201050
answer	answer is ministerial correction date of answer 23/06/2014 answer text <p>There are currently 15 products authorised in the United Kingdom containing nitrazepam and 15 different companies authorised to manufacture and distribute them.</p><p> </p><p>There are currently two products authorised in the UK containing flurazepam and one company authorised to manufacture and distribute them.</p><p> </p><p>There are currently two products authorised in the UK containing loprazolam and two different companies authorised to manufacture and distribute them.</p><p> </p><p>There are currently eight products authorised in the UK containing lormetazepam and four different companies authorised to manufacture and distribute them.</p><p> </p><p>There are currently 10 products authorised in the UK containing temazepam and six different companies authorised to manufacture and distribute them.</p><p> </p><p>There are currently six products authorised in the UK containing clonazepam and three different companies authorised to manufacture and distribute them.</p><p> </p><p>There are currently no authorised products in the UK containing medazepam.</p><p> </p><p>There are currently 22 products authorised in the UK containing midazolam and 10 different companies authorised to manufacture and distribute them.</p><p> </p><p>There are currently 17 products authorised in the UK containing zopiclone and nine different companies authorised to manufacture and distribute them.</p><p> </p><p>There are currently two products authorised in the UK containing zaleplon and one company authorised to manufacture and distribute them.</p><p> </p><p>There are currently 21 products authorised in the UK containing zolpidem and 12 different companies authorised to manufacture and distribute them.</p><p> </p><p>There are currently no authorised products in the UK containing eszopiclone.</p><p> </p><p>There are currently 238 products authorised in the UK containing SSRI antidepressants and 57 different companies authorised to manufacture and distribute them.</p><p> </p><p>There are currently 16 products authorised in the UK containing tricyclic antidepressants and 11 different companies authorised to manufacture and distribute them.</p><p> </p><p>One loprazolam, four lormetazepam, two clonazepam, two midazolam, three zopiclone, four zolpidem and 75 SSRI products have been authorised in the last three years.</p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb question first answered 23/06/2014 15:15:27 answering member 1439 label Biography information for Norman Lamb
tabling member	446 label Biography information for Jim Dobbin

60797

registered interest
date	09/06/2014
answering body	Attorney General
answering dept id	88
answering dept short name	Attorney General
answering dept sort name	Attorney General
hansard heading	GlaxoSmithKline
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Attorney General, what the terms of reference are for the investigation by the Serious Fraud Office (SFO) into GlaxoSmithKline (GSK); whether the SFO will investigate (a) GSK's activities within the UK, (b) allegations of bribery of UK doctors, (c) promotion of Seroxat prescribing for children and (d) the 2002 CSM Expert Working Group on the safety of SSRI antidepressants; and whether there is a point of contact for members of the public who wish to help the SFO investigation.
tabling member constituency	Heywood and Middleton
tabling member printed	Jim Dobbin
uin	199631
answer	answer is ministerial correction date of answer 12/06/2014 answer text <p>The Director of the Serious Fraud Office (SFO) recently announced that he has opened a criminal investigation into the commercial practices of GlaxoSmithKline plc and its subsidiaries. The SFO investigation will follow the evidence and it is not appropriate to comment whilst enquiries are continuing.</p><p>A press release regarding GlaxoSmithKline and information on how to contact the SFO can be found on its website at <a href="http://www.sfo.gov.uk/" target="_blank">www.sfo.gov.uk</a></p> answering member constituency Beaconsfield answering member printed Mr Dominic Grieve question first answered 12/06/2014 14:56:57 answering member 16 label Biography information for Mr Dominic Grieve
tabling member	446 label Biography information for Jim Dobbin

60798

registered interest
date	09/06/2014
answering body	Foreign and Commonwealth Office
answering dept id	16
answering dept short name	Foreign and Commonwealth Office
answering dept sort name	Foreign and Commonwealth Office
hansard heading	Gibraltar
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Foreign and Commonwealth Affairs, if he will take steps to ensure that the provisions of EU law in relation to the freedom to provide services apply to the provision of services from Gibraltar to any part of the EU.
tabling member constituency	Heywood and Middleton
tabling member printed	Jim Dobbin
uin	199703
answer	answer is ministerial correction date of answer 13/06/2014 answer text <p>Gibraltar is in the EU and is covered by EU treaty provisions on the freedom to provide services. We vigorously support all of Gibraltar's rights under the EU Treaties.</p> answering member constituency Aylesbury answering member printed Mr David Lidington question first answered 13/06/2014 10:21:18 answering member 15 label Biography information for Sir David Lidington
tabling member	446 label Biography information for Jim Dobbin

58158

registered interest
date	04/06/2014
answering body	Department for Environment, Food and Rural Affairs
answering dept id	13
answering dept short name	Environment, Food and Rural Affairs
answering dept sort name	Environment, Food and Rural Affairs
hansard heading	Water: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Environment, Food and Rural Affairs, pursuant to the Answer of 6 May 2014, Official Report, column 41W, on drinking water, whether his Department has conducted a study of levels of psychotropic drugs in UK rivers and seawater.
tabling member constituency	Heywood and Middleton
tabling member printed	Jim Dobbin
uin	198996
answer	answer is ministerial correction date of answer 09/06/2014 answer text <p> </p><p>Currently no psychotropic drugs have been identified as Priority Hazardous Substances, Priority Substances or UK Specific Pollutants under the Water Framework Directive. As such no routine monitoring is carried out for these substances in England.</p><p> </p><p> </p><p> </p><p>However, previous research by the Environment Agency on pharmaceuticals in surface waters included environmental monitoring for the psychotropic drug fluoxetine (an anti-depressant). In 2005, monitoring was undertaken in rivers downstream of a number of sewage works across England and Wales. Thirty-nine samples were taken with fluoxetine occurring in 85% of samples with a maximum concentration of 0.044 microgrammes/litre (µg/l), and norfluoxetine in 51% of samples with a maximum concentration of 0.083 µg/l.</p><p> </p><p> </p><p> </p><p>During 2011, a programme of monitoring for pesticides was undertaken in six catchments. The psychotropic drugs carbamazepine and gabapentin were detected in all six catchments with maximum levels of 0.7 µg/l and 1.2 µg/l respectively.</p><p> </p><p> </p><p> </p><p>The report published by the Drinking Water Inspectorate evaluated the risk from psychotropic drugs in river water used for abstraction for drinking water supplies.</p><p> </p> answering member constituency North Cornwall answering member printed Dan Rogerson question first answered 09/06/2014 13:37:10 answering member 1504 label Biography information for Dan Rogerson
tabling member	446 label Biography information for Jim Dobbin

58159

registered interest
date	04/06/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Terminal Illnesses
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many people in England in receipt of free social care are terminally ill.
tabling member constituency	Heywood and Middleton
tabling member printed	Jim Dobbin
uin	199001
answer	answer is ministerial correction date of answer 10/06/2014 answer text <p>Local authorities have a duty to assess the needs of any person for whom the authority may arrange social care and who may be in need of such care. They have a further duty to decide, having regard to the results of the assessment, what, if any, care and support they should provide to meet the individual's needs. Where a local authority decides to arrange care and support it will carry out a financial assessment to decide what an individual can afford to contribute towards the cost. Appeals against decisions by local authorities are considered locally. Information about appeals is not collected centrally.</p><p> </p><p>In its 2011 report, the independent Palliative Care Funding Review recommended the provision of free social care at the end of life. A series of palliative care funding pilots were established to test the review's recommendations, and these completed their work in March 2014. NHS England is currently analysing the financial data collected from the pilots. Once this analysis has been completed, a decision will be made on the issue of free social care at the end of life, taking into account this analysis and wider policy and financial considerations.</p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb grouped question UIN 198962 question first answered 10/06/2014 15:21:50 answering member 1439 label Biography information for Norman Lamb
tabling member	446 label Biography information for Jim Dobbin

58160

registered interest
date	04/06/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Social Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many appeals were made by applicants for social care at the end of their life in the last two years; how many such appeals were successful; and what proportion of total appeals against decisions about social care such appeals represent.
tabling member constituency	Heywood and Middleton
tabling member printed	Jim Dobbin
uin	198962
answer	answer is ministerial correction date of answer 10/06/2014 answer text <p>Local authorities have a duty to assess the needs of any person for whom the authority may arrange social care and who may be in need of such care. They have a further duty to decide, having regard to the results of the assessment, what, if any, care and support they should provide to meet the individual's needs. Where a local authority decides to arrange care and support it will carry out a financial assessment to decide what an individual can afford to contribute towards the cost. Appeals against decisions by local authorities are considered locally. Information about appeals is not collected centrally.</p><p> </p><p>In its 2011 report, the independent Palliative Care Funding Review recommended the provision of free social care at the end of life. A series of palliative care funding pilots were established to test the review's recommendations, and these completed their work in March 2014. NHS England is currently analysing the financial data collected from the pilots. Once this analysis has been completed, a decision will be made on the issue of free social care at the end of life, taking into account this analysis and wider policy and financial considerations.</p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb grouped question UIN 199001 question first answered 10/06/2014 15:21:49 answering member 1439 label Biography information for Norman Lamb
tabling member	446 label Biography information for Jim Dobbin